Many mammography units now have microfocal spots ranging in size from 0.09 to 0.4 mm for magnification radiography. On site measurements of these focal spots are not possible without invasive procedures if National Equipment Manufactures Association (NEMA) specifications are to be followed. This paper describes a method to perform such measurements expeditiously (1.5 h) and noninvasively. We describe how this method differs from NEMA test specifications, and report the test results of 22 units from ten manufacturers. Six of the focal spots were larger than the manufacturer's specifications which were based on current NEMA standards. Emphasis is placed on the need for verifiable standards for mammography x-ray systems.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1118/1.596264 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Addressing Breast Cancer Disparities: A Comprehensive Approach to Health Equity.
J Surg Oncol
December 2024
Department of Surgery, Morehouse School of Medicine, Atlanta, Georgia, USA.
This article addresses the persistent disparities in breast cancer outcomes across different racial, ethnic, and socioeconomic groups despite advancements in diagnosis and treatment. The disparities are rooted in various factors, including access to care, socioeconomic status, and cultural barriers. The article emphasizes the need for targeted interventions, such as expanding insurance coverage, mobile mammography units, and culturally tailored outreach programs to promote health equity.
View Article and Find Full Text PDFBreast cancer in Bulgaria prior implementation of a national breast cancer screening program and certified breast centers.
J Cancer Policy
December 2024
Medical University Pleven, Kliment Ohridski 1, Pleven 5800, Bulgaria; University of Essex, United Kingdom.
Introduction: Breast cancer (BC) survival has improved globally in the past years. Eastern Europe is a region with lack of epidemiological data and traditionally lower BC overall survival (OS). We aimed to investigate the epidemiology of BC in Bulgaria between 2012 and 2022 and the readiness of the state for implementing population based organized screening program.
View Article and Find Full Text PDFTechnical feasibility of automated blur detection in digital mammography using convolutional neural network.
Eur Radiol Exp
November 2024
Department of Diagnostic and Interventional Radiology, University Hospital Zürich, Zürich, Switzerland.
Background: The presence of a blurred area, depending on its localization, in a mammogram can limit diagnostic accuracy. The goal of this study was to develop a model for automatic detection of blur in diagnostically relevant locations in digital mammography.
Methods: A retrospective dataset consisting of 152 examinations acquired with mammography machines from three different vendors was utilized.
The Evolution of Artificial Intelligence in Medical Imaging: From Computer Science to Machine and Deep Learning.
Cancers (Basel)
November 2024
National Institute for Nuclear Physics (INFN), Pisa Division, 56127 Pisa, Italy.
Artificial intelligence (AI), the wide spectrum of technologies aiming to give machines or computers the ability to perform human-like cognitive functions, began in the 1940s with the first abstract models of intelligent machines. Soon after, in the 1950s and 1960s, machine learning algorithms such as neural networks and decision trees ignited significant enthusiasm. More recent advancements include the refinement of learning algorithms, the development of convolutional neural networks to efficiently analyze images, and methods to synthesize new images.
View Article and Find Full Text PDFCombining Contrast-Enhanced Mammography and Radioactive-Free Magnetic Seed Localization of Non-palpable Breast Tumors: A Feasibility Study.
J Cancer
October 2024
Zuyderland Medical Center, Department of Medical Imaging, Sittard-Geleen, the Netherlands.
Magnetic seed localization is a novel and reliable technique for perioperative localization of non-palpable breast cancers. However, due to susceptibility artifacts, magnetic seeds cannot be during response monitoring of neoadjuvant chemotherapy with MRI. Contrast-enhanced mammography (CEM) could provide an alternative modality for response monitoring while magnetic seeds are .
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!